The role of SREBP-1c signaling pathway in osteoblast pyroptosis and the protective effect of D-pinitol

Preclinical animal studies and human trials have indicated that D-pinitol may have multiple beneficial properties, such as regulating lipid metabolism and anti-osteoporosis. The purpose of this research was to use in vivo and in vitro methods to explore lipid-induced pyroptosis in osteogenic differentiation and osteoporosis development, while also examining DP's regulatory role in preventing osteoblast pyroptosis. Results demonstrated that daily oral administration of D-pinitol (DP) at a clinically relevant dose significantly ameliorated bone microarchitecture deterioration in apolipoprotein A1-deficient (ApoA1 −/− ) mice. DP increased Runx2 and OST expressions, and enhanced the bone-mineralized nodules production in ox-LDL-treated MC3T3-E1 cells. DP also lowered pyroptosis-related indicators such as NLRP3, Caspase-1, GSDMD, GSDMD N-terminal (GSDMD-NT), Cleaved caspase-1, and IL-1β. Mechanistically, we found that DP inhibited NLRP3-mediated pyroptosis by downregulating SREBP-1c and altering p53 and Galectin-1 signaling. Our findings indicated that SREBP-1c is involved in lipid metabolism disorder-induced activation of the NLRP3 and ultimately results in osteogenic pyroptosis. DP could inhibit the SREBP-1c pathway to protect osteoblasts, thereby ameliorating osteoporosis. Diagrammatic illustration of the working model showing how the DP inhibits the SREBP-1c signaling pathway to reduce osteoblast pyroptosis caused by lipid dysmetabolism. • DP administration inhibits bone pyroptosis and rescued bone loss in ApoA1−/− mice. • Ox-LDL-induced lipid accumulation caused osteoblasts to undergo pyroptotic cell death via SREBP-1 activation. • Treatment with DP markedly attenuated ox-LDL mediated the inhibition of bone formation and osteogenic pyroptosis. • DP inhibited the SREBP-1c pathway via altering its downstream signaling pathways, such as p-p53 and Galectin-1 to protect osteoblasts from lipid metabolic dysfunction-induced pyroptosis thereby ameliorating osteoporosis.

Authors

Institutions

Publication Details

Journal
Journal of Functional Foods
Published
2025-05-02
DOI
https://doi.org/10.1016/j.jff.2025.106846
Citations
1
Primary Topic
Inflammasome and immune disorders
Type
article
Field-Weighted Citation Impact
0.81
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The role of SREBP-1c signaling pathway in osteoblast pyroptosis and the protective effect of D-pinitol

Haiqing Gao, Baoying Li, Chaochao Dai, Xue Chao Wang et al.
1 citations
Journal of Functional Foods
Inflammasome and immune disorders
0.81
article

The role of SREBP-1c signaling pathway in osteoblast pyroptosis and the protective effect of D-pinitol

Haiqing Gao, Baoying Li, Chaochao Dai, Xue Chao Wang, Jie Wang, Yajuan Wang, Wenqian Zhao, Fang Li, Mei Cheng
article en
1 citations

Abstract

Preclinical animal studies and human trials have indicated that D-pinitol may have multiple beneficial properties, such as regulating lipid metabolism and anti-osteoporosis. The purpose of this research was to use in vivo and in vitro methods to explore lipid-induced pyroptosis in osteogenic differentiation and osteoporosis development, while also examining DP's regulatory role in preventing osteoblast pyroptosis. Results demonstrated that daily oral administration of D-pinitol (DP) at a clinically relevant dose significantly ameliorated bone microarchitecture deterioration in apolipoprotein A1-deficient (ApoA1 −/− ) mice. DP increased Runx2 and OST expressions, and enhanced the bone-mineralized nodules production in ox-LDL-treated MC3T3-E1 cells. DP also lowered pyroptosis-related indicators such as NLRP3, Caspase-1, GSDMD, GSDMD N-terminal (GSDMD-NT), Cleaved caspase-1, and IL-1β. Mechanistically, we found that DP inhibited NLRP3-mediated pyroptosis by downregulating SREBP-1c and altering p53 and Galectin-1 signaling. Our findings indicated that SREBP-1c is involved in lipid metabolism disorder-induced activation of the NLRP3 and ultimately results in osteogenic pyroptosis. DP could inhibit the SREBP-1c pathway to protect osteoblasts, thereby ameliorating osteoporosis. Diagrammatic illustration of the working model showing how the DP inhibits the SREBP-1c signaling pathway to reduce osteoblast pyroptosis caused by lipid dysmetabolism. • DP administration inhibits bone pyroptosis and rescued bone loss in ApoA1−/− mice. • Ox-LDL-induced lipid accumulation caused osteoblasts to undergo pyroptotic cell death via SREBP-1 activation. • Treatment with DP markedly attenuated ox-LDL mediated the inhibition of bone formation and osteogenic pyroptosis. • DP inhibited the SREBP-1c pathway via altering its downstream signaling pathways, such as p-p53 and Galectin-1 to protect osteoblasts from lipid metabolic dysfunction-induced pyroptosis thereby ameliorating osteoporosis.

Journal of Functional FoodsVol. 129
Jinan Central Hospital (CN), Qilu Hospital of Shandong University (CN), Shandong First Medical University (CN)
Openalex Percentile: Top 28%
Inflammasome and immune disorders
0.81
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.